Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Machine learning identifies lung cancer type

Dear Sir or Madam,

Machine learning and artificial intelligence currently touch many areas of medicine. Algorithms that are meant to recognize diseases better than physicians and are thus able to help them are researched around the world. Read in our news what this can look like in the case of lung cancer.

Have a relaxed week,

Timo Roth
Editorial team MEDICA-tradefair.com

image: 12 - 15 November 2018, MEDICA - World Forum for Medicine in Düsseldorf

Table of Contents

Topic of the Month: Digital OR
Newsletter Service
RSS Service
Newsletter Archive

Smart Hospital: How devices communicate in the OR

Topic of the Month

Image: Two physicians are looking at a model of a vascular system through 3D glasses; Copyright: Brainlab AG
In a Smart Hospital, all devices are designed to be connected and integrated, thus increasing efficiency and reducing time loss – at least, that is how things are meant to work in theory. In reality, there are still countless vendor-specific point solutions that cannot be integrated. That’s why there is a need for solutions that bridge the gap between the different applications and formats.
Read more in our Topic of the Month:
Smart Hospital: How devices communicate in the OR
Smart Hospital: Healthcare rethought
To top

Research & Technology

New test kit for quick, accurate and low-cost screening of diseases

A multidisciplinary team of researchers at the National University of Singapore (NUS) has developed a portable, easy-to-use device for quick and accurate screening of diseases. This versatile technology platform called enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) can be designed to detect a wide range of diseases.
read more
To top

Research & Technology

New means to fight "un-killable" bacteria in healthcare settings

Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes. Little is known about the mechanisms leading to tolerance, a strategy that makes bacteria "indifferent" to antibiotics and almost "un-killable," which results in chronic infections.
read more
To top

Research & Technology

Nikon Imaging Center opens at UC San Diego

Center will provide the latest in microscopic tools and technologies, including "super-resolution"
read more
To top

Research & Technology

New nanoparticles wait to release drugs, target infection

Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes. These microscopic particles are loaded with antibiotic and anti-inflammatory agents which are released when the particles encounter infection in the body.
read more
To top

Research & Technology

Wearable ultrasound patch monitors blood pressure

A new wearable ultrasound patch that non-invasively monitors blood pressure in arteries deep beneath the skin could help people detect cardiovascular problems earlier on and with greater precision. In tests, the patch performed as well as some clinical methods to measure blood pressure.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.